A Systematic Review of miR-29 in Cancer

Jason J. Kwon, Tricia D. Factora, Shatovisha Dey, Janaiah Kota

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

MicroRNAs (miRNA) are small non-coding RNAs (∼22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29’s functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.

Original languageEnglish (US)
Pages (from-to)173-194
Number of pages22
JournalMolecular Therapy - Oncolytics
Volume12
DOIs
StatePublished - Mar 29 2019

Fingerprint

MicroRNAs
Neoplasms
Genetic Epigenesis
Small Untranslated RNA
Immunomodulation
Regulator Genes
Oncogenes
Fibrosis
Apoptosis
Neoplasm Metastasis
Gene Expression

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Cite this

A Systematic Review of miR-29 in Cancer. / Kwon, Jason J.; Factora, Tricia D.; Dey, Shatovisha; Kota, Janaiah.

In: Molecular Therapy - Oncolytics, Vol. 12, 29.03.2019, p. 173-194.

Research output: Contribution to journalReview article

Kwon, Jason J. ; Factora, Tricia D. ; Dey, Shatovisha ; Kota, Janaiah. / A Systematic Review of miR-29 in Cancer. In: Molecular Therapy - Oncolytics. 2019 ; Vol. 12. pp. 173-194.
@article{8bf17337d9d3495a9822de987142944e,
title = "A Systematic Review of miR-29 in Cancer",
abstract = "MicroRNAs (miRNA) are small non-coding RNAs (∼22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29’s functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.",
author = "Kwon, {Jason J.} and Factora, {Tricia D.} and Shatovisha Dey and Janaiah Kota",
year = "2019",
month = "3",
day = "29",
doi = "10.1016/j.omto.2018.12.011",
language = "English (US)",
volume = "12",
pages = "173--194",
journal = "Molecular Therapy - Oncolytics",
issn = "2372-7705",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A Systematic Review of miR-29 in Cancer

AU - Kwon, Jason J.

AU - Factora, Tricia D.

AU - Dey, Shatovisha

AU - Kota, Janaiah

PY - 2019/3/29

Y1 - 2019/3/29

N2 - MicroRNAs (miRNA) are small non-coding RNAs (∼22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29’s functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.

AB - MicroRNAs (miRNA) are small non-coding RNAs (∼22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29’s functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.

UR - http://www.scopus.com/inward/record.url?scp=85061162852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061162852&partnerID=8YFLogxK

U2 - 10.1016/j.omto.2018.12.011

DO - 10.1016/j.omto.2018.12.011

M3 - Review article

AN - SCOPUS:85061162852

VL - 12

SP - 173

EP - 194

JO - Molecular Therapy - Oncolytics

JF - Molecular Therapy - Oncolytics

SN - 2372-7705

ER -